BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/09/2023

FDA Announces Draft Guidance for Industry on Graft-Versus-Host Diseases Prevention and Treatment

The US Food and Drug Administration (FDA) has released a draft guidance document to help pharmaceutical companies develop drugs, biological products, and devices to prevent or treat acute and chronic graft-versus-host diseases (aGVHD and cGVHD), a serious complication of stem cell transplants.

Source: Federal Register — Food and Drug AdministrationOpen original release →